Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sath Shukla Insider Profile
4 Followers
Sath Shukla, EVP & CFO at Alaunos Therapeutics, holds 1.14M shares in Spero Therapeutics (Ticker: SPRO), holds 80.50K shares in Alaunos Therapeutics (Ticker: TCRT). Most recently, Sath Shukla Sold ― shares of Spero Therapeutics on Aug 29, 2024 for an estimated value of 3.72K.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+11.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sath Shukla holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sath Shukla
Sath Shukla's Trading History
Alaunos Therapeutics
Jan 31, 2020
EVP & CFO
Uninformative Buy
―
$157.78K
Spero Therapeutics
Aug 29, 2024
CEO & President
Informative Sell
3.72K
$1.09M
List of latest transactions for each holding click on a transaction to see Sath Shukla's performance on stock
You May Also Like
Sath Shukla insider profile FAQ
What is the percentage of profitable transactions made by Sath Shukla?
The percentage of profitable transactions made by Sath Shukla is 100%.
What is the average return per transaction made by Sath Shukla?
The average return per transaction made by Sath Shukla is 11.40%.
What stocks does Sath Shukla hold?
Sath Shukla holds: TCRT, SPRO stocks.
What was Sath Shukla’s latest transaction?
Sath Shukla latest transaction was an Informative Sell of $3.72K.
What was Sath Shukla's most profitable transaction?
Sath Shukla’s most profitable transaction was an Informative Sell of SPRO stock on February 5, 2024. The return on the trade was 18.70%.
What is Sath Shukla's role in Alaunos Therapeutics?
Sath Shukla's role in Alaunos Therapeutics is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.